Novavax shares up on fourth quarter earnings beat [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
The company is transitioning away from direct commercialization of its COVID-19 vaccine. The vaccine maker posted a fourth-quarter loss per share of $0.51, beating analysts' expectations of a 60-cent loss on each share. Revenue came in at $88.31 million, below the consensus estimate of $102.74 million. Novavax said it was transitioning away from commercial responsibilityof its COVID-19 vaccine, Nuvaxovid, giving it to Sanofi (NASDAQ:SNY) starting with the 2025-2026 season. The company also secured a $50 million milestone payment under its Sanofi agreement and completed the $200 million sale of its Czech Republic manufacturing facility to Novo Nordisk (NYSE:NVO), a move expected to reduce annual costs by about $80 million. The company
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- RFK Jr. Responds To Report He's Considering Removing COVID-19 Vaccines From CDC Schedule [zero hedge]zero hedge
- How Will RFK’s Cuts At The CDC, FDA And NIH Affect You? [Forbes]Forbes
- Novavax says its COVID-19 shot is on track for full FDA approval after delay [Yahoo! Finance Canada]Yahoo! Finance Canada
- Novavax jumps after FDA asks for more data on its Covid vaccine [Yahoo! Finance]Yahoo! Finance
- SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/27/25 - Beat
NVAX
Sec Filings
- 4/23/25 - Form 8-K
- 4/14/25 - Form 144
- 4/2/25 - Form 8-K
- NVAX's page on the SEC website